David Saltissi

815 total citations
30 papers, 587 citations indexed

About

David Saltissi is a scholar working on Surgery, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Saltissi has authored 30 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Nephrology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Saltissi's work include Dialysis and Renal Disease Management (8 papers), Lipoproteins and Cardiovascular Health (6 papers) and Renal Transplantation Outcomes and Treatments (3 papers). David Saltissi is often cited by papers focused on Dialysis and Renal Disease Management (8 papers), Lipoproteins and Cardiovascular Health (6 papers) and Renal Transplantation Outcomes and Treatments (3 papers). David Saltissi collaborates with scholars based in Australia, United Kingdom and Saudi Arabia. David Saltissi's co-authors include Justin Westhuyzen, Helen Healy, D J Rainford, Charles D. Pusey, Lionel L.O. Bloodworth, Russell J. Rigby, David Macfarlane, John Rowell, J. Atherton and Michael J. Greenwood and has published in prestigious journals such as Kidney International, Annals of the Rheumatic Diseases and American Journal of Kidney Diseases.

In The Last Decade

David Saltissi

30 papers receiving 559 citations

Peers

David Saltissi
Chike Nzerue United States
Udayan Bhatt United States
Charles J. Diskin United States
Joana Gameiro Portugal
Joon Seok Choi South Korea
Erika J. Martin United States
Chike Nzerue United States
David Saltissi
Citations per year, relative to David Saltissi David Saltissi (= 1×) peers Chike Nzerue

Countries citing papers authored by David Saltissi

Since Specialization
Citations

This map shows the geographic impact of David Saltissi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Saltissi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Saltissi more than expected).

Fields of papers citing papers by David Saltissi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Saltissi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Saltissi. The network helps show where David Saltissi may publish in the future.

Co-authorship network of co-authors of David Saltissi

This figure shows the co-authorship network connecting the top 25 collaborators of David Saltissi. A scholar is included among the top collaborators of David Saltissi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Saltissi. David Saltissi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Henderson, Robert D., David Saltissi, & Michael P. Pender. (2009). Case report Goodpasture's syndrome associated with multiple sclerosis. Acta Neurologica Scandinavica. 98(2). 134–135. 6 indexed citations
2.
Saltissi, David, et al.. (2006). Efficacy, safety and tolerability of atorvastatin in dyslipidemic subjects with advanced (non-nephrotic) and endstage chronic renal failure. Clinical and Experimental Nephrology. 10(3). 201–209. 4 indexed citations
3.
Greenwood, Michael J., et al.. (2005). Dosing strategy for enoxaparin in patients with renal impairment presenting with acute coronary syndromes. British Journal of Clinical Pharmacology. 59(3). 281–290. 47 indexed citations
4.
Johnson, David W., John Agar, John Collins, et al.. (2003). Recommendations for the use of icodextrin in peritoneal dialysis patients. Nephrology. 8(1). 1–7. 36 indexed citations
5.
Westhuyzen, Justin, et al.. (2003). Oxidative stress and erythrocyte integrity in end-stage renal failure patients hemodialysed using a vitamin E-modified membrane.. PubMed. 33(1). 3–10. 12 indexed citations
6.
Saltissi, David, et al.. (2002). Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis. American Journal of Kidney Diseases. 39(2). 283–290. 64 indexed citations
7.
MacGinley, Robert, et al.. (2001). Evaluation of a Novel Vitamin E Coated Cellulosic Membrane Hollow Fiber Dialyzer. ASAIO Journal. 47(1). 66–73. 11 indexed citations
8.
Saltissi, David, et al.. (2001). Effect of lipid-lowering dietary recommendations on the nutritional intake and lipid profiles of chronic peritoneal dialysis and hemodialysis patients. American Journal of Kidney Diseases. 37(6). 1209–1215. 17 indexed citations
9.
Rigby, Russell J., et al.. (1999). A double‐blind placebo controlled trial of simvastatin for the treatment of dyslipidaemia in renal allograft recipients. Clinical Transplantation. 13(6). 520–525. 20 indexed citations
10.
Saltissi, David, et al.. (1999). Comparison of low-molecular-weight heparin (enoxaparin sodium) and standard unfractionated heparin for haemodialysis anticoagulation. Nephrology Dialysis Transplantation. 14(11). 2698–2703. 75 indexed citations
11.
Murphy, Brendan F., David C.H. Harris, Alex Disney, et al.. (1999). Treatment of peritoneal dialysis related peritonitis—an Australian and New Zealand perspective. Australian and New Zealand Journal of Medicine. 29(4). 552–555. 6 indexed citations
12.
Rigby, R., et al.. (1997). Simvastatin efficacy in renal transplant subjects with hyperlipidemia. Kidney International. 51(4). 1315–1316. 1 indexed citations
13.
Westhuyzen, Justin, et al.. (1997). Simplified Sizing of Low-Density Lipoprotein Using Polyacrylamide Gradient Gel Electrophoresis of Plasma. Clinical Chemistry and Laboratory Medicine (CCLM). 35(1). 17–20. 5 indexed citations
14.
Westhuyzen, Justin, David Saltissi, & Helen Healy. (1997). Oxidation of low density lipoprotein in hemodialysis patients: effect of dialysis and comparison with matched controls. Atherosclerosis. 129(2). 199–205. 37 indexed citations
15.
Westhuyzen, Justin, et al.. (1997). Low‐density lipoprotein subfraction profiles in dialysis patients. Nephrology. 3(2). 169–177. 7 indexed citations
16.
Westhuyzen, Justin, et al.. (1992). Effect of Dialyzer Reprocessing with Renalin on Serum Beta-2-Microglobulin and Complement Activation in Hemodialysis Patients. American Journal of Nephrology. 12(1-2). 29–36. 24 indexed citations
17.
Saltissi, David, et al.. (1986). Inappropriate Secretion of Antidiuretic Hormone Following Aminoglutethimide Therapy. British Journal of Urology. 58(6). 724–725. 1 indexed citations
18.
Saltissi, David, Gerald A. Coles, J. A. F. Napier, & P.J. Bentley. (1984). The hematological response to continuous ambulatory peritoneal dialysis.. PubMed. 22(1). 21–7. 24 indexed citations
20.
Saltissi, David, et al.. (1983). Haemodialysis for severe mixed drug overdosage.. PubMed. 36(7-8). 286–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026